Taking BENLYSTA (belimumab)

Are you ready to talk to your doctor about adding BENLYSTA?

Build a treatment plan that works for you

BENLYSTA is the only biologic treatment for lupus and lupus nephritis that offers flexibility for at-home or infusion options.

Administering BENLYSTA At Home

BENLYSTA for subcutaneous (SC) use is an at-home injection for adults and children ages 5 years and older. This injection can be taken after you or a caregiver are trained by a healthcare provider.

 

  • How: You will be taking BENLYSTA with either an autoinjector or a prefilled syringe (for adults only).
  • When: BENLYSTA should be taken exactly as prescribed by your doctor.
  • Filling your prescription: Receive BENLYSTA from your specialty pharmacy, and store in a refrigerator.

 

Get more information and watch a video on how to use the autoinjector.

Receiving BENLYSTA Intravenous (IV) Infusions

You can receive BENLYSTA intravenous (IV) infusions with the comfort of having a healthcare provider monitor you during and immediately after the infusion.

 

  • How: You and your care team will decide on the infusion plan together to determine whether to receive it at the doctor’s office, an infusion center, or a hospital.
  • When: BENLYSTA is taken once every 2 weeks for doses 1-3 then once every 4 weeks after that for both lupus and lupus nephritis.
  • Getting your infusion: It takes about 1 hour to give you the full dose of BENLYSTA.

 

Get more information and watch a video about the IV infusion experience.

Cost Support for BENLYSTA

Every month, eligible patients save on BENLYSTA.

Real Patient Stories

Nadine’s Story

“Go to your doctor's appointments, take your medication [as prescribed]. Seriously, take it! It can be hard to remember, but you need to take all of your medications. I never forget to take my BENLYSTA shot.”

Smiling BENLYSTA patient Nadine wearing a yellow shirt while standing outside
Nadine, real BENLYSTA patient compensated by GSK

Approved Use & Safety Info

Approved Use

Important Safety Information

Approved Use

What is BENLYSTA?

BENLYSTA is a prescription medicine used to treat adults and children 5 years of age and older with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis (LN) (lupus-related kidney inflammation) who are receiving other lupus medicines. It is not known if BENLYSTA is safe/effective in people with severe active central nervous system lupus.

 

It is not known if BENLYSTA is safe and effective for use in children less than 5 years of age.

 

It is not known if BENLYSTA, given under the skin (subcutaneously), is safe and effective for use in children who weigh less than 33 pounds (15 kilograms).

Important Safety Information

Do not use BENLYSTA if you are allergic to belimumab or any ingredients in BENLYSTA.

 

The most important information about BENLYSTA

 

Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these may cause death.

  • Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
  • Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen the day of, or in days after, receiving BENLYSTA and may cause death.
  • Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.

 

Before receiving BENLYSTA, discuss with your healthcare provider if you:

  • think you have an infection or have infections that keep coming back. Do not use BENLYSTA if you have an infection unless your healthcare provider tells you to.
  • have or have had mental health problems such as depression or thoughts of suicide.
  • have recently received or may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
  • are taking any medicines, including prescription, over-the-counter, vitamins, and herbal supplements.
  • are allergic to other medicines.
  • are receiving other biologic medicines.  
  • have or have had any type of cancer.
  • have any other medical conditions.
  • are pregnant or plan to become pregnant. It is unknown if BENLYSTA will harm your unborn baby. Talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control for at least 4 months after the final dose of BENLYSTA.
  • become pregnant while receiving BENLYSTA, talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-311-8972 or go to https://mothertobaby.org/ongoing-study/benlysta-belimumab/.
  • are breastfeeding or plan to breastfeed. It is unknown if BENLYSTA passes into your breast milk.

 

Possible side effects of BENLYSTA

  • Progressive multifocal leukoencephalopathy (PML). PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
  • Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

 

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

 

Please see Prescribing Information and Medication Guide for BENLYSTA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report negative side effects to GSK at gsk.public.reportum.com or 1-888-825-5249.
GSK Help Center logo

Explore the GSK Help Center website to find customer service support and contact information.

Pay as little as zero dollars

Eligible commercially insured patients may pay as little as $0 for BENLYSTA, subject to program maximums.*

*Program annual maximums apply. Visit BenlystaCopayProgram.com for information about eligibility and full program terms and conditions.